Protamine hypersensitivity has been documented by intra-dermal skin testing in three patients who demonstrated sudden cardiovascular collapse and bronchospasm following the use of intravenous protamine sulphate. All patients had been given protamine previously. The effects of the anaphylactic response were terminated quickly by the administration of intravenous adrenaline associated with plasma volume expansion. Intra-dermal skin testing against all anaesthetic agents is recommended so that the specific allergen can be identified. In patients who are shown to be allergic to protamine sulphate and who require cardiac or vascular surgery careful monitoring of heparin dosage and neutralisation with hexadimethrine (Polybrene) intravenously appears to be a safe alternative.
INTRODUCTION
Protamine sulphate is now widely used to reverse the effects of heparin following cardiac and vascular surgical procedures. Protamine hypersensitivity has been a rare phenomenon. However, in certain patients the repeated administration of intravenous protamine appears to result in an anaphylactic reaction. The resulting cardiovascular collapse may be profound requiring urgent treatment with adrenaline and plasma volume expansion. Three patients in whom protamine hypersensitivity was documented by skin testing illustrate some of the problems associated with this condition.
CASE REPORTS Case One
Mr. H.R. presented in March 1978 with a three month history of increasing angina.
Coronary angiography revealed a stenosis of the circumflex and right coronary arteries. Heparin 5,000 units (50 mg) was used during the angiogram and was reversed with protamine sulphate 50 mg without incident. At coronary artery bypass three weeks later, heparin 200 mg was reversed uneventfully with protamine sulphate 300 mg. Six months later, following a recurrence of his symptoms he had a further coronary angiogram. Heparin 50 mg used during angiography was reversed again without incident using protamine sulphate 50 mg.
In March 1980 a further coronary angiogram was performed because of continuing angina. At the completion of the angiogram, 35 mg of protamine sulphate was infused intravenously. This resulted in profound hypotension, abdominal pain, loss of consciousness, apnoea and cardiac arrest. His circulation was restored rapidly after adrenaline 500 JAg, promethazine 25 mg and hydrocortisone 500 mg were given intravenously. Initial volume expansion was achieved by a rapid infusion of Haemaccel (Hoechst) 500 ml. The central venous pressure following this infusion was only 1 cm of water and a further 1000 ml of stable plasma protein solution (S.P.P .S.) was given intravenously to restore the blood pressure to normal. Following resuscitation, his white cell count rose from 6,000 to 15,000 cells/mml and blood gas analysis revealed a metabolic acidosis. Chest x-ray showed no evidence of pulmonary oedema.
Seven weeks later intra-dermal skin testing was performed according to Fischer's protoco!I using thiopentone, suxamethonium, heparin, pancuronium, atropine, neostigmine, protamine sulphate, morphine sulphate, hexadimethrine 2 (Polybrene) and saline. A positive result was seen only with protamine sulphate 1: 1000. A weal greater than 1 cm in diameter appeared in less than three minutes and lasted longer than 30 minutes.
Subsequently, a further coronary artery graft was applied to the left anterior descending coronary artery. The activated clotting time was used to monitor the response to heparin 240 mg. The estimated residual dose of heparin was reversed with hexadimethrine 100 mg (0.7 mg of hexadimethrine was used to neutralise each milligram of circulating heparin). The patient had an uneventful recovery.
Case Two
Mr. R.H. presented with transient weakness of the right side of his face associated with a tight stenosis and ulceration of the origin of each internal carotid artery. A left carotid endarterectomy was performed in September 1979. Heparin 100 mg was given intravenously prior to clamping the carotid artery and at the end of the procedure, the heparin was reversed using protamine sulphate 100 mg without incident.
A right carotid endarterectomy was performed six weeks later. Again, heparin 100 mg was given intravenously and at the end of the procedure heparin reversal was begun with 15 mg of protamine sulphate. The patient developed a bradycardia followed by cardiac arrest associated with severe bronchospasm. Hydrocortisone 500 mg and promethazine 25 mg were given intravenously without apparent effect. However, following intravenous adrenaline 300 /-Ig, circulation was restored and bronchospasm relieved. His blood pressure returned to normal after administration of S.P.P.S. 1000 ml.
A post-operative chest x-ray revealed no evidence of pulmonary oedema. An electrocardiogram showed evidence of S-T elevation across the anterior chest leads but there was no abnormality in the creatine phosphokinase and lactic dehydrogenase enzyme systems. Full blood examination, blood gas analysis, coagulation profile and serum electrolytes were normal. Intra-dermal skin testing was performed against all the anaesthetic agents. l A positive result was seen only with protamine sulphate 1: 1000.
Case Three
Mr. J.M., a diabetic, had been treated for many years with protamine zinc insulin which was discontinued because of a rash at the site of injection. He was changed to isophane insulin (NPH) 16 units subcutaneously daily which he tolerated well. In January 1980, he suffered an anterior myocardial infarct following which he was disabled by angina pectoris.
Four months later he underwent cardiac catheterisation using Renographin 76!J!o and heparin 50 mg. His condition remained stable throughout the procedure until only 10 mg of protamine sulphate was given intravenously when he developed facial oedema and stridor followed by a cardiac arrest and loss of consciousness. He was resuscitated rapidly following the administration of adrenaline 500 /-Ig and hydrocortisone 250 mg given intravenously.
A triple coronary artery bypass was performed four weeks later. At operation heparin dosage was monitored using the activated clotting time. At the end of the procedure the residual heparin was neutralised with hexadimethrine 150 mg which restored the activated clotting time to normal. There were no unusual post-operative features. After intradermal skin testing with 1: 1000 protamine sulphate solution a 3 cm weal developed rapidly. There was no reaction to any of the other anaesthetic agents. DISCUSSION An anaphylactic response to protamine sulphate appears to be the most likely cause of the profound cardiovascular collapse in these three patients. Each patient had been exposed previously to protamine sulphate or protamine zinc insulin. Cardiovascular collapse occurred immediately following intravenous administration of protamine sulphate. Further, hypersensitivity to protamine sulphate was Anaesthesia and Intensive Care, Vol. IX, No. 2, May, 1981 confirmed on intra-dermal skin testing in all three patients I and finally, all responded immediately to intravenous adrenaline solution.
The clinical features in all three patients strongly suggested a Type I anaphylactic response to protamine presumably mediated by IgE antiprotein antibodies bound to mast cells. 3, 4 There are several ways in which a Type I reaction can be caused, the IgE mechanism being the commonest. 4 In a susceptible patient IgE or IgG is produced in response to the initiating d0se of protamine sulphate. These immuno-proteins are attached to mast cells and basophils through the Fc fragment. After a waiting period of several weeks the second exposure to protamine results in combination of the antigen with the IgE or IgG complex which triggers degranulation of mast cells or basophils with mediator release. Other mechanisms involve immune complexes, complement and anaphylactoid type of reactions. In the two patients who collapsed following angiography (cases One and Three) the possibility of an anaphylactoid reaction to the x-ray dye should be considered. However, this would seem unlikely as collapse did not correspond chronologically with the infusion of the radio-opaque dye but occurred at the end of the procedure immediately after a small intravenous dose of protamine sulphate.
The vasoactive properties of protamine sulphate have been known for many years. 3 In both man 5 and dog 6 intravenous injection of protamine causes a rapid decrease in systemic vascular resistance associated with a fall in cardiac output and hypotension. In addition there is a sustained increase in pulmonary vascular resistance. 5 These effects are minimised by infusing protamine sulphate slowly and using the smallest effective dose. 7 Prompt resuscitation with intravenous adrenaline and plasma volume expansion was successful in all three patients who were considered high risk because of their widespread vascular disease. Intravenous adrenaline exerts a beneficial effect during Anaesthesia and Intensive Care, Vol. IX, No. 2, May. 1981 anaphylaxis by reversing vasodilatation caused by the vasoactive amines and by overcoming the smooth muscle contraction and thus relieving bronchospasm.
Intra-dermal skin testing was useful in confirming that all three patients were sensitive to protamine sulphate. The procedure was simple and easy to perform and the results in these patients were unequivocal. I Our current policy in patients who have had previous exposure to protamine sulphate is to use an initial small test dose of 5-10 mg. Intravenous adrenaline and plasma volume expanding agents are always available. 8 Should a reaction occur, the patient is skin -tested against all the agents used. When a further cardiac or vascular surgical procedure is performed in a patient with documented protamine hypersensitivity intravenous hexadimethrine (Polybrene) is used as an alternative to protamine sulphate for heparin reversal.
